Results 31 to 40 of about 1,192 (128)
Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy
Abstract INTRODUCTION A subset of Alzheimer's disease (AD) patients exhibits a procoagulant state that remains undiagnosed despite available treatments. We developed positron emission tomography (PET) strategies to in vivo detect cerebral microthrombi in TgCRND8 mice. METHODS PET was performed with a fibrin‐binding probe (FBP) in TgCRND8 and wild‐type
Carlos Ceron +22 more
wiley +1 more source
Prevalence of high‐risk plasma p‐tau217 levels and 5‐year transition of risk status in 70‐year‐olds
Abstract INTRODUCTION High‐risk plasma p‐tau217 levels predict amyloid‐β pathology in Alzheimer's disease, but little is known about the prevalence and temporal dynamics in the general population. METHODS Participants from the Gothenburg H70 Birth Cohort Study in Sweden were examined (n = 1157) and re‐examined after 5–7 years (n = 771).
Anna Dittrich +9 more
wiley +1 more source
NUTRIÇÃO E DOENÇA DE ALZHEIMER: BREVE REVISÃO
A doença de Alzheimer (DA) é uma doença degenerativa, caracterizada por perdas nas funções cognitivas que afetam linguagem, memória, coordenação e atenção. É a demência mais incidente em idosos, acometendo 50-70% dessa população.
Elizabeth Maria Coppola Campos +6 more
doaj
ABSTRACT Introduction Although frailty is considered a potentially modifiable risk factor for dementia, its influence on health outcomes in individuals with established dementia remains unclear. This study aims to systematize the current evidence to understand the impact of frailty on the development of adverse outcomes in older adults with dementia ...
Miguel German Borda +11 more
wiley +1 more source
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source
A RELAÇÃO ENTRE A PRIVAÇÃO DO SONO E A DOENÇA DE ALZHEIMER: UMA REVISÃO INTEGRATIVA
Introdução: A privação de sono participa de diversos processos neuropatológicos, inclusive na fisiopatologia da Doença de Alzheimer, demência progressiva e multifatorial com morbimortalidade crescente.
Fillipe Silva Tourinho +7 more
doaj +1 more source
Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare SORL1 variants
Abstract INTRODUCTION The sortilin‐related receptor (SORL1) directs APP and Aβ trafficking within the retromer pathway. Cleavage at the cell surface releases soluble SORL1 (sSORL1) into cerebrospinal fluid (CSF). We examined whether CSF‐sSORL1 can serve as an in vivo marker of genetically impaired SORL1.
Matthijs W. J. de Waal +24 more
wiley +1 more source
Uso de anticolinesterásicos na doença de Alzheimer
A doença de Alzheimer (DA) é a causa mais comum de demência, caracterizada por início insidioso e curso progressivo, com declínio cognitivo, comprometimento da autonomia e da capacidade de realização de atividades de vida diária, alterações de humor e ...
Kellen Klein Pereira +1 more
doaj +1 more source
Abstract INTRODUCTION Pretangle tau inclusions from the locus coeruleus (LC) are hypothesized to propagate to the entorhinal cortex (EC) via neuron‐to‐neuron transmission along its projections. The lower integrity of the LC‐EC pathway accompanying Alzheimer's disease (AD) pathology is supported by post mortem studies, but in vivo evidence remains ...
Yuliya Patsyuk +10 more
wiley +1 more source
Detection of TDP‐43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS
Abstract INTRODUCTION Seed amplification assays (SAAs) have shown promising results in detecting misfolded transactive response (TAR) DNA‐binding protein 43 (TDP‐43) in cerebrospinal fluid (CSF) of genetic frontotemporal dementia (FTD). To date, the use of SAA has yet to be evaluated in presymptomatic individuals.
Ilaria Linda Dellarole +20 more
wiley +1 more source

